Autoimmunity Reviews

Article	Citations
Editorial Board	332
T lymphocyte plasticity in chronic inflammatory diseases: The emerging role of the Ikaros family as a key Th17-Treg switch	166
Endometriosis and autoimmunity	156
Susac syndrome: A scoping review	131
Issues in autoantibody tests used in the classification criteria for autoimmune rheumatic diseases: the laboratory autoimmunologist's perspective	122
“Fibromyalgia syndrome” related to Essure devices	106
Editorial Board	99
Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disorders	97
Leflunomide: A safe and effective alternative in systemic lupus erythematosus	92
Autoantibody internalization in myositis skeletal muscle: Emerging evidence, mechanistic insights, and therapeutic relevance	88
Osteonecrosis in systemic lupus erythematosus: Systematic insight from the epidemiology, pathogenesis, diagnosis and management	86
Lymphocyte activation gene-3 (LAG-3) regulatory T cells: An evolving biomarker for treatment response in autoimmune diseases	86
Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysis	84
Characteristics and risk factors for infection in patients with ANCA-associated vasculitis: A systematic review and meta-analysis	81
The role of musculoskeletal ultrasound in difficult-to-treat RA: Insights from a systematic literature review	80
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence	77
MTHFR polymorphisms in autoimmune diseases: Mechanistic and clinical perspectives	77
Epidemiological patterns and in-hospital mortality in ANCA-associated vasculitis: Insights from Spain's National Health Data (2016–2022)	75
Corrigendum to “Proportion of circulating T follicular helper cells in peripheral blood of systemic lupus erythematosus patients: A systematic review and meta-analysis” [Autoimmunity Reviews Volume 24	73
The immune system in Hashimoto's thyroiditis: Updating the current state of knowledge on potential therapies and animal model construction	73
Psychiatric manifestations of autoimmune encephalitis	72
Fecal microbiota transplantation in autoimmune diseases – An extensive paper on a pathogenetic therapy	68
Can anticoagulation be withdrawn in APS patients after aPL negativization?	67
Conceiving complexity: Biological mechanisms underpinning the lasting effect of pregnancy on multiple sclerosis outcomes	64
Advances in precision medicine in imaging and therapeutic strategies for psoriatic disease	61

Editorial Board	58
A call for uniformity in reporting patient level details during description of ophthalmologic major relapse among giant cell arteritis studies. A comment on article by Aussedat M et al. “Epidemiology	58
STING-inflammasome axis in autoimmune diseases and inflammation-related disease	55
Understanding the effects of Janus kinase inhibitors on the cardiovascular system in comparison to main biological DMARDs in rheumatoid arthritis	54
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered	53
To treat or not to treat rheumatoid arthritis with glucocorticoids? A reheated debate	50
Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature	50
Homocysteine as a trigger and potential therapeutic target for autoimmune diseases	48
Worsening of Graves' ophthalmopathy after SARS-CoV-2 mRNA vaccination	47
Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy	47
Seronegative autoimmune diseases: A challenging diagnosis	47
Autoimmunity in vitiligo: Therapeutic implications and opportunities	47
Rebalancing redox homeostasis: A pivotal regulator of the cGAS-STING pathway in autoimmune diseases	47
Autoimmune pre-disease	46
WITHDRAWN: Global incidence trends of autoimmune diseases from 1990 to 2021 and projections to 2050: A systemic analysis of the global burden of disease study 2021	46
Editorial Board	45
Human abdominal aortic aneurysm (AAA): Evidence for an autoimmune antigen-driven disease.	45
Systematic evaluation of the associations between schizophrenia and autoimmune diseases: An umbrella review	45
Indian Rheumatology Association guidelines for the management of ANCA associated vasculitis	45
Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium	44
Editorial Board	43
Inclusion body myositis: Correcting impaired mitochondrial and lysosomal autophagy as a potential therapeutic strategy	43
SpA plus IBD or IBD plus SpA: Does commutative property apply?	42
A descriptive study of IgG4-related disease in children and young adults	41
A machine learning analysis to predict the response to intravenous and subcutaneous immunoglobulin in inflammatory myopathies. A proposal for a future multi-omics approach in autoimmune diseases	41
Research progress on estrogen and estrogen receptors in the occurrence and progression of autoimmune thyroid diseases	40
The genealogy, methodology, similarities and differences of immune reconstitution therapies for multiple sclerosis and neuromyelitis optica	39
Cerebral vasculitis as a clinical manifestation of neurosarcoidosis: A scoping review	39
Refining search and keyword strategies in autoimmune ear disease bibliometric studies	38
Specialized pro-resolving mediators and autoimmunity: Recent insights and future perspectives	38
Adipose failure through adipocyte overload and autoimmunity	38
Exosomes as biomarkers and therapeutic delivery for autoimmune diseases: Opportunities and challenges	38
Standardised interpretation of capillaroscopy in autoimmune idiopathic inflammatory myopathies: A structured review on behalf of the EULAR study group on microcirculation in Rheumatic Diseases	38
IFN-γ: An overlooked cytokine in dermatomyositis with anti-MDA5 antibodies	38
Predicting autoimmune diseases: A comprehensive review of classic biomarkers and advances in artificial intelligence	37
Factors associated with fertility abnormalities in women with systemic lupus erythematosus: a systematic review and meta-analysis	36
Controversies in in rheumatology and autoimmunity: Is CORA meeting a good educational tool to increase the scientific knowledge?	36
Effects of cytotoxic T-lymphocyte-associated protein 4 compared to TNF inhibitors on lipid profile: Results from an observational multicentre rheumatoid arthritis cohort	36
Editorial Board	35
Complex relationships of type 2 and type 1 symptoms across various systemic autoimmune diseases.	35
Are breast cancer patients diagnosed after systemic sclerosis showing different pathological characteristics?	33
Fibromyalgia: Are we using the biopsychosocial model?	33
Antibiotic-induced gut dysbiosis and autoimmune disease: A systematic review of preclinical studies	32
Chronic inflammation in Long COVID relationship to autoimmune diseases	32
Pathogenesis, clinical features, and treatment strategy for rheumatoid arthritis-associated interstitial lung disease	32
Development of an algorithm for IgG4-related disease management	32
Editorial Board	31
Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines	31
The role of mitochondrial dysfunction in kidney injury and disease	31
Factors associated with incident cardiovascular disease in patients with rheumatoid arthritis: A scoping review	31

Tumor necrosis factor-α inhibitor-related autoimmune disorders	31
The similar expression of both ferritin and scavenger receptors activation genes in patients with COVID19 and AOSD support their role in the pathogenesis of these diseases and identify a common mechan	30
Will a hyperactive classical complement pathway exacerbate autoimmune diseases?	30
Editorial Board	30
Editorial Board	30
Combination tacrolimus and ustekinumab therapy is effective in inducing clinical, biochemical and endoscopic remission in refractory moderate to severe ulcerative colitis	29
Reply letter to letter to the editor	29
Dysfunction of the glymphatic system and sleep disturbance in rheumatoid arthritis and musculoskeletal pain: A gap related to pain becoming chronic	29
Are IF-ANA the guiding light for SLE classification in the real-world setting?	29
Differences in clinical phenotype, laboratory, and imaging manifestations between AQP4 IgG positive and AQP4 MOG IgG double negative NMOSD: How to correctly diagnose the two	28
Mucous membrane pemphigoid	28
Proportion of circulating T follicular helper cells in peripheral blood of systemic lupus erythematosus patients: A systematic review and meta-analysis	28
A machine learning analysis to evaluate the outcome measures in inflammatory myopathies	28
Alarmins in autoimmune diseases	28
Coffee consumption and risk of multiple sclerosis: A systematic review and meta-analysis	28
Twenty shades of the mosaic of autoimmunity	28
Mesenchymal stem cell in immunomodulation of dendritic cells: Implications for inflammatory bowel disease therapy	28
Anti-rods/rings autoantibodies in a patient with pancreatic injury	28
From autoantibody test results to decision making: Incorporating likelihood ratios within medical practice	27
Global burden due to modifiable risk factors for autoimmune diseases, 1990–2021: Temporal trends and socio-demographic inequalities	27
Impact of GLP-1 analogues on immune-mediated inflammatory diseases: A systematic review	27
In Memoriam: Pierre Youinou	26
Low-dose intravenous immunoglobulin (IVIg) in different immune-mediated conditions	26
Mucosal immunity and rheumatoid arthritis: An update on mechanisms and therapeutic potential	26
Neuroimaging in thyroid eye disease: A systematic review	26
Cutting edge confusion about cut-off settings in autoimmune diagnostics	26
The impact of pregnancy on future health in Rheumatoid Arthritis: A systematic review of the literature	26
Editorial Board	26
Is it time for treat-to-target in antiphospholipid syndrome?	25
IL-33 in Spondyloarthritis, the missing key	25
Diagnostic approach in giant cell arteritis	25
Burden of inflammatory bowel disease among elderly, 1990–2019: A systematic analysis based on the global burden of disease study 2019	25
Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) in 2023	25
Macrophages in Lupus Nephritis: Exploring a potential new therapeutic avenue	24
Genetic and genomic associations in antiphospholipid syndrome: A systematic review	24
Potential immunological and genetic markers associated with lupus nephritis: From pathogenicity to therapeutic drug target	24
Editorial Board	24
Subcutaneous tissue involvement in idiopathic inflammatory myopathies: Systematic literature review including three new cases and hypothetical mechanisms	24
Prevalence of immune-mediated inner ear disease in non-segmental vitiligo: A cross-sectional study	24
Prevention of rheumatoid arthritis: A systematic literature review of preventive strategies in at-risk individuals	23
Epidemiology of major relapse in giant cell arteritis: A study-level meta-analysis	23
JAK inhibitors and systemic sclerosis: A systematic review of the literature	23
Differentially expressed genes in systemic sclerosis: Towards predictive medicine with new molecular tools for clinicians	23
Serum calprotectin is a marker of disease activity in Giant cell arteritis	23
Gut microbiota in rheumatoid arthritis: Mechanistic insights, clinical biomarkers, and translational perspectives	22
Development of systemic lupus erythematosus in patients with immune thrombocytopenic purpura: A systematic meta-analysis	22
Ferritinophagy in inflammatory and autoimmune diseases: Mechanistic insights and therapeutic potentials	22
Extending the discussion: Cannabis based therapies in inflammatory bowel disease a letter to the editor	22
Treatment of acute exacerbation in interstitial lung disease secondary to autoimmune rheumatic diseases: More questions than answers	22
Inflammatory muscle involvement in systemic vasculitis: A systematic review	22
Risk factors associated with thrombocytopenia in systemic lupus erythematosus: A systematic review and meta-analysis	21
Persistent aortic inflammation in patients with giant cell arteritis	21
Intermittent fasting: A promising dietary intervention for autoimmune diseases	21
From inflammation to renal fibrosis: A one-way road in autoimmunity?	21
Persistence of antiphospholipid antibodies over time and its association with recurrence of clinical manifestations: A longitudinal study from a single centre	21
Editorial Board	21
Don't mix apples and oranges. Reply to Azoulay et al.	21
Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): Recent and advanced data	21
Glomerulonephritis and inflammatory bowel disease: A tale of gut-kidney axis dysfunction	21
Research advances on targeted-Treg therapies on immune-mediated kidney diseases	21
Drug-induced antiphospholipid syndrome: Analysis of the WHO international database	20
Editorial Board	20
Therapeutic potential of chimeric antigen receptor based therapies in autoimmune diseases	20
Structural cell heterogeneity underlies the differential contribution of IL-17A, IL-17F and IL-23 to joint versus skin chronic inflammation	20
Physical exercise therapy for autoimmune neuroinflammation: Application of knowledge from animal models to patient care	20
Identifying subsets of patients with undifferentiated connective tissue disease: Results from a prospective, real-world experience using particle-based multi-analyte technology	20
Scleroderma cardiac crisis: A-life-threatening but reversible complication of systemic sclerosis	20
The emerging concept of ANCA-associated vasculitis related to inborn errors of immunity	19
Clinical features, pathogenesis, and treatment of inflammatory bowel disease-associated spondyloarthritis	19
Cerebral iron accumulation in multiple sclerosis: Pathophysiology and therapeutic implications	19
Relapse rates and risk factors for unfavorable neurological prognosis of transverse myelitis in systemic lupus erythematosus: A systematic review and meta-analysis	19
IgG4 in the gut: Gastrointestinal IgG4-related disease or a new subtype of inflammatory bowel disease	19
Rapid radiographic progression in rheumatoid arthritis: Definition, prediction and treatment	19
Anti-glomerular basement membrane vasculitis	19
Inhibitors of Bruton's tyrosine kinase as emerging therapeutic strategy in autoimmune diseases	19
Janus kinase inhibitors for psoriatic arthritis: Evidence from a systematic review and network meta-analysis	18
Emerging roles of mechanically activated ion channels in autoimmune disease	18
Prevention of rheumatoid arthritis using a familial predictive medicine approach	18
The threat of triple M and autoimmune overlap syndromes with immune checkpoint inhibitors - A series of case reports	18
The assessment and management of bone health in pediatric-onset rheumatological diseases from early age to adulthood: A critical overview	18

Recommendations for the use of anti-dsDNA autoantibodies in the diagnosis and follow-up of systemic lupus erythematosus – A proposal from an expert panel	18
Autoantibodies against tyrosyl-tRNA synthetase (anti-Ha antibodies)	18
Insights into new-onset autoimmune diseases after COVID-19 vaccination	18
Advancing understanding of autoimmune disease-related interstitial lung disease (AD-ILD): A global perspective on research focus and future directions	17
Prevalence of anti-Ro52-kDa/SSA (TRIM21) antibodies and associated clinical phenotype in systemic sclerosis: Data from a French cohort, a systematic review and meta-analysis	17
The interferon in idiopathic inflammatory myopathies: Different signatures and new therapeutic perspectives. A literature review	17
Involvement of aquaporin 5 in Sjögren’s syndrome	17
Autoimmune effector mechanisms associated with a defective immunosuppressive axis in immune thrombocytopenia (ITP)	17
Regulated cell death in systemic lupus erythematosus: Key pathways and targeted therapies	16
Editorial Board	16
Letter to the editor regarding a meta-analysis of JAK inhibitors and psoriatic arthritis	16
Takotsubo syndrome occurring in systemic diseases: A French multicenter retrospective case-control study and literature review	16
Exploring vaccine safety and adverse events in major autoimmune diseases	16
Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management	16
Thyroid autoimmunity and SARS-CoV-2 infection: Report of a large Italian series	16
Editorial Board	16
Pursuing appropriateness in antiphospholipid antibodies testing: Feasibility study with a reflex test approach for anti-β2GPI I domain	16
Severe treatment-refractory antibody positive autoimmune autonomic ganglionopathy and COVID19 vaccination: Correspondence	16
Systemic lupus erythematosus in critical care: A systematic review of ICU outcomes and management	16
The role of bDMARDs in idiopathic inflammatory myopathies: A systematic literature review	16
Exercise-induced modulation of Interferon-signature: a therapeutic route toward management of Systemic Lupus Erythematosus	16
Does a window of opportunity for rheumatoid arthritis-associated interstitial lung disease exist?	16